Clinical Trial: Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure
Study Status: Available
Recruit Status: Available
Study Type: Expanded Access
Official Title: Clinical Protocol to Treat Individuals With Tecovirimat (ST-246) After Exposure to Orthopox Viruses
Brief Summary: The purpose of this clinical protocol is to treat individuals with Tecovirimat after exposure to orthopox viruses.
Detailed Summary:
Sponsor: U.S. Army Medical Research and Materiel Command
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: U.S. Army Medical Research and Materiel Command
Dates:
Date Received: March 4, 2014
Date Started:
Date Completion:
Last Updated: November 10, 2016
Last Verified: August 2016